• Je něco špatně v tomto záznamu ?

Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion

A. Dodge, MM. Peters, HE. Greene, C. Dietrick, R. Botelho, D. Chung, J. Willman, AW. Nenninger, S. Ciarlone, SG. Kamath, P. Houdek, A. Sumová, AE. Anderson, SV. Dindot, EL. Berg, H. O'Geen, DJ. Segal, JL. Silverman, EJ. Weeber, KR. Nash

. 2020 ; 13 (3) : 397-409. [pub] 20200121

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012817

Grantová podpora
R01 NS097808 NINDS NIH HHS - United States
U54 HD079125 NICHD NIH HHS - United States

Angelman syndrome (AS) is a rare genetic disorder characterized by severe intellectual disability, seizures, lack of speech, and ataxia. The gene responsible for AS was identified as Ube3a and it encodes for E6AP, an E3 ubiquitin ligase. Currently, there is very little known about E6AP's mechanism of action in vivo or how the lack of this protein in neurons may contribute to the AS phenotype. Elucidating the mechanistic action of E6AP would enhance our understanding of AS and drive current research into new avenues that could lead to novel therapeutic approaches that target E6AP's various functions. To facilitate the study of AS, we have generated a novel rat model in which we deleted the rat Ube3a gene using CRISPR. The AS rat phenotypically mirrors human AS with loss of Ube3a expression in the brain and deficits in motor coordination as well as learning and memory. This model offers a new avenue for the study of AS. Autism Res 2020, 13: 397-409. © 2020 International Society for Autism Research,Wiley Periodicals, Inc. LAY SUMMARY: Angelman syndrome (AS) is a rare genetic disorder characterized by severe intellectual disability, seizures, difficulty speaking, and ataxia. The gene responsible for AS was identified as UBE3A, yet very little is known about its function in vivo or how the lack of this protein in neurons may contribute to the AS phenotype. To facilitate the study of AS, we have generated a novel rat model in which we deleted the rat Ube3a gene using CRISPR. The AS rat mirrors human AS with loss of Ube3a expression in the brain and deficits in motor coordination as well as learning and memory. This model offers a new avenue for the study of AS.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012817
003      
CZ-PrNML
005      
20210507101612.0
007      
ta
008      
210420s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/aur.2267 $2 doi
035    __
$a (PubMed)31961493
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Dodge, Andie $u Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida
245    10
$a Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion / $c A. Dodge, MM. Peters, HE. Greene, C. Dietrick, R. Botelho, D. Chung, J. Willman, AW. Nenninger, S. Ciarlone, SG. Kamath, P. Houdek, A. Sumová, AE. Anderson, SV. Dindot, EL. Berg, H. O'Geen, DJ. Segal, JL. Silverman, EJ. Weeber, KR. Nash
520    9_
$a Angelman syndrome (AS) is a rare genetic disorder characterized by severe intellectual disability, seizures, lack of speech, and ataxia. The gene responsible for AS was identified as Ube3a and it encodes for E6AP, an E3 ubiquitin ligase. Currently, there is very little known about E6AP's mechanism of action in vivo or how the lack of this protein in neurons may contribute to the AS phenotype. Elucidating the mechanistic action of E6AP would enhance our understanding of AS and drive current research into new avenues that could lead to novel therapeutic approaches that target E6AP's various functions. To facilitate the study of AS, we have generated a novel rat model in which we deleted the rat Ube3a gene using CRISPR. The AS rat phenotypically mirrors human AS with loss of Ube3a expression in the brain and deficits in motor coordination as well as learning and memory. This model offers a new avenue for the study of AS. Autism Res 2020, 13: 397-409. © 2020 International Society for Autism Research,Wiley Periodicals, Inc. LAY SUMMARY: Angelman syndrome (AS) is a rare genetic disorder characterized by severe intellectual disability, seizures, difficulty speaking, and ataxia. The gene responsible for AS was identified as UBE3A, yet very little is known about its function in vivo or how the lack of this protein in neurons may contribute to the AS phenotype. To facilitate the study of AS, we have generated a novel rat model in which we deleted the rat Ube3a gene using CRISPR. The AS rat mirrors human AS with loss of Ube3a expression in the brain and deficits in motor coordination as well as learning and memory. This model offers a new avenue for the study of AS.
650    _2
$a Angelmanův syndrom $x genetika $x patofyziologie $7 D017204
650    _2
$a zvířata $7 D000818
650    _2
$a mozek $x patofyziologie $7 D001921
650    _2
$a modely nemocí na zvířatech $7 D004195
650    12
$a delece genu $7 D017353
650    _2
$a lidé $7 D006801
650    _2
$a paměť $7 D008568
650    _2
$a fenotyp $7 D010641
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Sprague-Dawley $7 D017207
650    _2
$a ubikvitinligasy $x genetika $7 D044767
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Peters, Melinda M $u Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida
700    1_
$a Greene, Hayden E $u Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida
700    1_
$a Dietrick, Clifton $u Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida
700    1_
$a Botelho, Robert $u Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida
700    1_
$a Chung, Diana $u Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida
700    1_
$a Willman, Jonathan $u Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida
700    1_
$a Nenninger, Austin W $u Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida
700    1_
$a Ciarlone, Stephanie $u Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida $u PTC Therapeutics Inc., Plainfield, 07080, New Jersey
700    1_
$a Kamath, Siddharth G $u Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida
700    1_
$a Houdek, Pavel $u Department of Neurohumoral Regulations, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Sumová, Alena $u Department of Neurohumoral Regulations, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Anderson, Anne E $u Department of Pediatrics, Baylor College of Medicine, Houston, Texas
700    1_
$a Dindot, Scott V $u Department of Veterinary Pathobiology, Texas A&M, College Station, Texas
700    1_
$a Berg, Elizabeth L $u School of Medicine, MIND Institute, Department of Psychiatry and Behavioral Sciences, University of California - Davis, Sacramento, California
700    1_
$a O'Geen, Henriette $u Genome Center and MIND Institute, University of California - Davis, Davis, California
700    1_
$a Segal, David J $u Genome Center and MIND Institute, University of California - Davis, Davis, California
700    1_
$a Silverman, Jill L $u School of Medicine, MIND Institute, Department of Psychiatry and Behavioral Sciences, University of California - Davis, Sacramento, California
700    1_
$a Weeber, Edwin J $u Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida $u PTC Therapeutics Inc., Plainfield, 07080, New Jersey
700    1_
$a Nash, Kevin R $u Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida
773    0_
$w MED00157624 $t Autism research : official journal of the International Society for Autism Research $x 1939-3806 $g Roč. 13, č. 3 (2020), s. 397-409
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31961493 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507101612 $b ABA008
999    __
$a ok $b bmc $g 1651062 $s 1133196
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 13 $c 3 $d 397-409 $e 20200121 $i 1939-3806 $m Autism research $n Autism Res $x MED00157624
GRA    __
$a R01 NS097808 $p NINDS NIH HHS $2 United States
GRA    __
$a U54 HD079125 $p NICHD NIH HHS $2 United States
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace